RG-2833

N/A

Report date: 2025/06/24 16:51:50
NME

Base Information

Drug NameRG-2833
Drug Alias NameRG-2833RGFP-109RG2833RG-FA
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 3 inhibitorsHistone deacetylase 1 inhibitors
TargetsHistone deacetylase 3Histone deacetylase 1
Therapy Area/IndicationsFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute IncRepligen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRepligenRepligen CorpThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsFriedreich Ataxia

Other Information

ATC CodeN/A
Related LinksN/A